Skip to main content
Erschienen in: Journal of Clinical Immunology 3/2024

Open Access 01.03.2024 | Correspondence

Non-Helicobacter pylori Helicobacter Species as a Cause of Refractory Chronic Cellulitis in X-Linked Agammaglobulinemia

verfasst von: Qianqian Zhao, Jijun Ma, Jiawen Wu, Abdurahman Matruzi, Chongwei Li

Erschienen in: Journal of Clinical Immunology | Ausgabe 3/2024

Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s10875-024-01668-y.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
To the Editor,
X-linked agammaglobulinemia (XLA) is an inborn error of immunity (IEI) first described in 1952 and has a prevalence of 1:100,000 to 1:200,000 [1]. A loss-of-function mutation in Bruton’s tyrosine kinase (BTK) gene results in B-cell maturation failure and defective antibody production. XLA is generally characterized by recurrent infections, agammaglobulinemia, and a percentage of circulating CD19+ B cells less than 2%. Sinopulmonary infections are common in XLA, while skin infections are also significant. Non-Helicobacter pylori Helicobacter (NHPH) species, representing a rare cause of chronic conditions in XLA patients, are challenging to detect and eradicate [2]. In this paper, we aim to explain the characteristic features of NHPH infections in XLA patients. Moreover, we present a rational and efficient method for diagnosing and treating these formidable infections.

Case Description

A 17-year-old boy was admitted to our Department due to a 5-year history of skin infections. He lived in a rural area, and his family raised pigs in the yard. There was no family history of immunodeficiency. He developed perianal abscess at 3 months of age, suffered from septicaemia caused by Pseudomonas aeruginosa infection at 16 months of age and cutaneous abscess at 22 months of age. At the time of examination, no tonsillar tissue was present. Immunological evaluation revealed extremely low levels of IgG (10 mg/dl), IgA (2 mg/dl), IgM (0 mg/dL), and CD19+ circulating B cells (0%). Whole-exome sequencing revealed a frameshift mutation (1581-1584de1TTTG) in exon 16 of the BTK gene (p.Cys527trpfsX2). He was on irregular replacement therapy with intravenous immunoglobulin (IVIG) (trough IgG level = 30–143 mg/dL). At 12 years of age, he had demarcated, hyperpigmented, painful, macular, and indurated plaques on his right ankle extensor surface accompanied by an irregular fever. By 14 years of age, the lesion had spread from the right ankle to the tibial regions of both legs (Fig. 1a, b). Monthly IVIG replacement (500–800 mg/kg; trough IgG level = 600–800 mg/dL) was initiated; however, the lower extremity lesions persisted. At 17 years of age, the lower extremity cellulitis worsened, with pyoderma gangrenosum (PG)-like leg ulcers (Fig. 1c, d) and lymphangitis in the right lower extremity accompanied by recurrent moderate-to-high fever. Routine blood tests revealed the following: white blood cell count, 6.5–14.83 × 109/L; 75–82% neutrophils, and 10–15% lymphocytes. Other laboratory results were normal, except for an elevated CRP level (12.67–70.99 mg/L, normal value = 0–8 mg/L). Previous conventional blood and pus cultures were negative. The patient’s guardians declined skin biopsy. The lesions responded well to cefoperazone/sulbactam and linezolid combined treatment. Nevertheless, relapse episodes occurred following antibiotic treatment cessation, and the patient eventually developed cefoperazone-sulbactam sodium and linezolid resistance during prolonged therapy. He was treated with cefepime, vancomycin, amoxicillin, amikacin, levofloxacin, and ertapenem successively; however, all of these antibiotics demonstrated transient efficacy or inefficacy. Two months later, incision and drainage were performed, revealing chocolate-colored pus. Metagenomic next-generation sequencing (mNGS) was also conducted to determine the causative agent. H. equorum and H. canadensis were identified in both blood and pus. Subsequently, the patient was treated with intravenous fosfomycin sodium (4 g, every 8 hours) combined with imipenem-cilastatin sodium (0.5 g, every 6 hours). He was afebrile and showed improvement in his cellulitis on the second day, and his CRP level normalized rapidly. Simultaneously, the boy presented with neutropenia (1.07×109/L). Additionally, the patient displayed hypersthenuria (urine-specific gravity ≥1.037), urobilinogenuria (urobilinogen 3+), and proteinuria (urine protein 1+) while maintaining normal renal function. After 10 weeks of intravenous antibiotic treatment, the PG-like ulcer resolved, with only pigmentation remaining (Fig. 1e, f). The antibiotics doxycycline (100 mg twice daily) and rifampin (450 mg once daily) were orally administered for the next ten weeks. The patient was stable after oral maintenance therapy, and his complete blood count and urine analysis gradually normalized within 2 months after antibiotic discontinuation. The 15-month posttherapy follow-up showed no cellulitis recurrence.

Discussion

Helicobacter is a genus of gram-negative bacteria characterized by their spiral shape and microaerophilic nature. NHPH species are zoonotic and may be linked to exposure to pigs in our case [2]. The most clinically significant NHPH species are H. cinaedi and H. bilis. However, sporadic cases of H. equorum and H. canadensis have also been reported [3, 4]. Many different symptoms are caused by these species, including recurrent fevers, abdominal abscesses, bacteraemia, osteomyelitis, arthritis, cellulitis, and PG-like ulcers. Culture is a traditional method with time-consuming and lowest positive rate due to the fastidious nature of NHPH. Most cases are identified by 16S sequencing, which is faster and more accurate than culture; however, as with other approaches (including polymerase chain reaction and mass spectrometry), accessibility is a major problem that hinders its clinical use. Given that mNGS assays for a diverse range of agents in an unbiased manner, it has the potential to enhance the detection of pathogens that may have been missed by clinicians or previously methods. Our case study highlights the significance of mNGS as a rapid, noninvasive, and valuable tool. The most important drawback of mNGS is the inability to identify antibiotic susceptibility.
Moreover, our case study reveals distinctive indications of infections with H. equorum and H. canadensis in XLA patients [4]. Specifically, the lower extremities are frequently affected, with lesions initially appearing as hyperpigmented and indurated areas that progress over months to years to form well-defined, painful macules, or chronic ulcers. Local factors (trauma) may contribute to the persistence of lesions on the lower extremities compared with the upper extremities. Individuals with XLA are prone to a proinflammatory state, rendering them susceptible to developing PG or PG-like lesions [2]. Characteristic skin lesions are significant clinical indicators in patients with disseminated NHPH infections. More clinical manifestations of XLA with NHPH infections are available in Table S1.
NHPH species are predominantly extracellular bacteria with extensive genetic mechanisms to escape host defenses, which contribute to their ability to persist. They are resistant to multiple antibiotic classes. For example, H. canadiensi and its isolates are resistant to azithromycin, ampicillin, clarithromycin, levofloxacin, and ciprofloxacin [2]. Unfortunately, there is no consensus treatment for NHPH infections. Overall, the antibiotics reported to be effective at eradicating this infection are broad-spectrum antibiotics, including a combination of two or more antibiotics. Our case showed that intravenous fosfomycin sodium combined with imipenem cilastatin sodium and sequential doxycycline combined with rifampicin were effective. A summary of antibiotics regimens used (failed and successful with durations) is available in Table S2. Our patient was claustrophobic and did not tolerate hyperbaric oxygen therapy (HBO); however, HBO may be a potential adjunctive therapy for patients with refractory chronic cellulitis for it alleviates inflammation, maintains wound oxygenation, and stimulates wound repair. NHPH infections are rare but significant causes of cellulitis in XLA patients. The lack of IgA in XLA patients may contribute to their susceptibility to disseminated infections. Consequently, adequate IVIG treatment and normal serum IgG levels do not appear to provide complete protection against NHPH infections in XLA patients [2, 5].
In conclusion, NHPH infections should be considered when cellulitis is refractory in patients with XLA, even if IgG levels are normal. NHPH species are challenging to identify using conventional microbiological techniques. Therefore, mNGS may be crucial for detecting these elusive microorganisms. Given the risk of recurrence, a combination of antibiotics and prolonged duration of therapy may be required for effective management, along with drug toxicity monitoring and close follow-up.

Acknowledgements

The authors thank the patient and his parents for their willingness to work with us and for their trust.

Code Availability

Not applicable.

Declarations

Ethics Approval

This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments and was approved by the Ethics Committee for Research of Tianjin Children’s Hospital.
The subject has given consent to participate.
Written informed consent was obtained from the patient’s parents for the publication of this case report and accompanying images.

Conflict of Interest

The authors have no relevant financial or non-financial interests to disclose.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt bestellen und 100 € sparen!

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Jetzt bestellen und 100 € sparen!

Literatur
1.
Zurück zum Zitat Cardenas-Morales M, Hernandez-Trujillo VP. Agammaglobulinemia: from X-linked to autosomal forms of disease. Clin Rev Allergy Immunol. 2022;63(1):22–35.CrossRefPubMed Cardenas-Morales M, Hernandez-Trujillo VP. Agammaglobulinemia: from X-linked to autosomal forms of disease. Clin Rev Allergy Immunol. 2022;63(1):22–35.CrossRefPubMed
2.
Zurück zum Zitat Romo-Gonzalez C, Bustamante-Ogando JC, Yamazaki-Nakashimada MA, Aviles-Jimenez F, Otero-Mendoza F, Espinosa-Rosales FJ, et al. Infections with enterohepatic non-H. pylori Helicobacter species in X-linked agammaglobulinemia: clinical cases and review of the literature. Front Cell Infect Microbiol. 2022;11(4):807136.CrossRefPubMedPubMedCentral Romo-Gonzalez C, Bustamante-Ogando JC, Yamazaki-Nakashimada MA, Aviles-Jimenez F, Otero-Mendoza F, Espinosa-Rosales FJ, et al. Infections with enterohepatic non-H. pylori Helicobacter species in X-linked agammaglobulinemia: clinical cases and review of the literature. Front Cell Infect Microbiol. 2022;11(4):807136.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Fox JG, Chien CC, Dewhirst FE, Paster BJ, Shen Z, Melito PL, et al. Helicobacter canadensis sp. nov. Isolated from humans with diarrhea as an example of an emerging pathogen. J Clin Microbiol. 2000;38(7):2546–9.CrossRefPubMedPubMedCentral Fox JG, Chien CC, Dewhirst FE, Paster BJ, Shen Z, Melito PL, et al. Helicobacter canadensis sp. nov. Isolated from humans with diarrhea as an example of an emerging pathogen. J Clin Microbiol. 2000;38(7):2546–9.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Funato M, Kaneko H, Ohkusu K, Sasai H, Kubota K, Ohnishi H, et al. Refractory chronic pleurisy caused by helicobacter equorum-like bacterium in a patient with X-linked agammaglobulinemia. J Clin Microbiol. 2011;49(9):3432–5.CrossRefPubMedPubMedCentral Funato M, Kaneko H, Ohkusu K, Sasai H, Kubota K, Ohnishi H, et al. Refractory chronic pleurisy caused by helicobacter equorum-like bacterium in a patient with X-linked agammaglobulinemia. J Clin Microbiol. 2011;49(9):3432–5.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Schwarze-Zander C, Becker S, Wenzel J, Rockstroh JK, Spengler U, Yassin AF. Bacteremia caused by a novel helicobacter species in a 28-year-old man with X-linked agammaglobulinemia. J Clin Microbiol. 2010;48(12):4672–6.CrossRefPubMedPubMedCentral Schwarze-Zander C, Becker S, Wenzel J, Rockstroh JK, Spengler U, Yassin AF. Bacteremia caused by a novel helicobacter species in a 28-year-old man with X-linked agammaglobulinemia. J Clin Microbiol. 2010;48(12):4672–6.CrossRefPubMedPubMedCentral
Metadaten
Titel
Non-Helicobacter pylori Helicobacter Species as a Cause of Refractory Chronic Cellulitis in X-Linked Agammaglobulinemia
verfasst von
Qianqian Zhao
Jijun Ma
Jiawen Wu
Abdurahman Matruzi
Chongwei Li
Publikationsdatum
01.03.2024
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 3/2024
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-024-01668-y

Weitere Artikel der Ausgabe 3/2024

Journal of Clinical Immunology 3/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.